Literature DB >> 25465940

Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker.

Christopher Porterfield1, John P DiMarco1, Pamela K Mason2.   

Abstract

The subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an important alternative to traditional ICD therapy. The major limitation of this technology is the inability to provide pacing. Here, we present a case of a patient with complete heart block and a pacemaker who underwent placement of an S-ICD. Special considerations had to be taken with regards to evaluation and implantation of the S-ICD because of the pacemaker. In conclusion, implantation of an S-ICD can be done in patients with pacemaker effectively with appropriate electrocardiographic screening, device testing, and programming.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25465940     DOI: 10.1016/j.amjcard.2014.10.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Limitations in S-ICD therapy: reasons for system explantation.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-07-07       Impact factor: 5.460

2.  Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system.

Authors:  Konstantinos Kossidas; Richard Kalman; William P Follis; Joshua M Cooper
Journal:  HeartRhythm Case Rep       Date:  2017-09-01

3.  Combination of a leadless pacemaker and subcutaneous defibrillator: First in-human report.

Authors:  Blandine Mondésert; Marc Dubuc; Paul Khairy; Peter G Guerra; Gilbert Gosselin; Bernard Thibault
Journal:  HeartRhythm Case Rep       Date:  2015-07-30

4.  Nothing inside the heart - Combining epicardial pacing with the S-ICD.

Authors:  Christian Steinberg; Santabhanu Chakrabarti; Andrew D Krahn; Jamil Bashir
Journal:  HeartRhythm Case Rep       Date:  2015-09-04

5.  Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.

Authors:  Hideyuki Hasebe; Tomoyo Yokoya; Nobuyuki Murakoshi; Nobutake Kurebayashi
Journal:  Intern Med       Date:  2019-09-03       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.